NOT-DC-24-014: Notice of Participation of NIDCD in NOT-OD-24-032 "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"

Notice of Participation of NIDCD in NOT-OD-24-032 "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"

Notice Number:

NOT-DC-24-014

Key Dates

Release Date:

December 21, 2023

Related Announcements

December 4, 2023 - "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional). See NOT-OD-24-032

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to inform potential applicants of NIDCD's participation, effective immediately, in, NOT-OD-24-032 "Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)

The following text has been added to reflect NIDCD's participation in this NOSI:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Deafness and Other Communication Disorders (NIDCD)

93.173

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Trinh T. Ly, MD
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-4085
Email: [email protected]

Financial/Grants Management Contact(s)

Christopher Myers
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-402-0909
Email: [email protected]

Inquiries

Please direct all inquiries to:

Jean Verheyden, MD, MPH
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 240-935-7070
Email: [email protected]